RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NTLA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Intellia Therapeutics Inc stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session.
(Updated on Mar 27, 2024)

Hold candidate since Mar 27, 2024 PDF

The Intellia Therapeutics Inc stock price gained 2.89% on the last trading day (Wednesday, 27th Mar 2024), rising from $26.26 to $27.02. During the last trading day the stock fluctuated 5.29% from a day low at $26.08 to a day high of $27.46. The price has fallen in 6 of the last 10 days and is down by -5.76% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 199 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $30.73 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.05% during the next 3 months and, with a 90% probability hold a price between $24.74 and $33.69 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NTLA Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 2.89%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Intellia Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $27.15 and $28.51. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Intellia Therapeutics Inc stock

Intellia Therapeutics Inc finds support from accumulated volume at $26.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.38 between high and low, or 5.29%. For the last week, the stock has had daily average volatility of 4.07%.

Our recommended stop-loss: $25.60 (-5.24%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (NTLA) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Intellia Therapeutics Inc to open at $26.85, and during the day (based on 14 day Average True Range), to move between $25.51 and $28.53, which gives a possible trading interval of +/-$1.51 (+/-5.59%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 11.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $26.45 (2.11%) than the resistance at $31.02 (14.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Intellia Therapeutics Inc stock A Buy?

Intellia Therapeutics Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.321 Hold/Accumulate Upgraded

Predicted Opening Price for Intellia Therapeutics Inc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$26.85 ( 0.617%) $27.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NTLA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 28.23 4.49 %
R2 27.71 2.54 %
R1 27.38 1.33 %
Current price: 27.02
Support S1 26.33 -2.57 %
S2 26.00 -3.77 %
S3 25.47 -5.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 32.80 21.39 %
R2 32.12 18.87 %
R1 31.02 14.80 %
Current price 27.02
Support S1 26.45 -2.11%
S2 25.26 -6.51%
S3 24.59 -8.99%

FAQ

What is the symbol for Intellia Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Intellia Therapeutics Inc is NTLA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Intellia Therapeutics Inc Stock?
Intellia Therapeutics Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Intellia Therapeutics Inc Stock?
Intellia Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Intellia Therapeutics Inc Stock.

What's the current price of Intellia Therapeutics Inc Stock?
As of the end of day on the 2024-03-27, the price of an Intellia Therapeutics Inc (NTLA) share was $27.02.

What is the 52-week high and low for Intellia Therapeutics Inc Stock?
The 52-week high for Intellia Therapeutics Inc Stock is $47.48 and the 52-week low is $22.67.

What is the market capitalization of Intellia Therapeutics Inc Stock?
As of the 2024-03-27, the market capitalization of Intellia Therapeutics Inc is 2.597B.

When is the next earnings date for Intellia Therapeutics Inc?
The upcoming earnings date for Intellia Therapeutics Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT